Application of metrizamide in the radiographic evaluation of the neurologically diseased patient.

K. R. Maravilla, Edward Neuwelt, J. T. Diehl

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Metrizamide (Amipaque) is a new water-soluble contrast agent for use in the intrathecal space. Extensive animal and clinical studies have demonstrated its low toxicity. The advantages to the use of metrizamide include the fact that it is miscible with cerebrospinal fluid and can fill narrow spaces, is sufficiently radiopaque to outline delicate structures within the central nervous system, is completely resorbed from the subarachnoid space, and, to date, has not been implicated in the formation of adhesive arachnoiditis. Application of metrizamide to the evaluation of neurologically diseased patients has included myelography, intracranial cisternography, and ventriculography, as well as various techniques in conjunction with computerized tomography. These various uses of metrizamide are discussed together with some indications and advantages. Metrizamide has now replaced Pantopaque and gas as the most commonly used intrathecal contrast agent at the University of Texas Health Science Center at Dallas.

Original languageEnglish (US)
Pages (from-to)389-406
Number of pages18
JournalNeurosurgery
Volume5
Issue number3
StatePublished - Sep 1979
Externally publishedYes

Fingerprint

Metrizamide
Contrast Media
Iophendylate
Arachnoiditis
Myelography
Subarachnoid Space
Adhesives
Cerebrospinal Fluid
Central Nervous System
Gases
Tomography
Water
Health

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Application of metrizamide in the radiographic evaluation of the neurologically diseased patient. / Maravilla, K. R.; Neuwelt, Edward; Diehl, J. T.

In: Neurosurgery, Vol. 5, No. 3, 09.1979, p. 389-406.

Research output: Contribution to journalArticle

@article{f675ca5d75f944fcac9aeacdb1777c42,
title = "Application of metrizamide in the radiographic evaluation of the neurologically diseased patient.",
abstract = "Metrizamide (Amipaque) is a new water-soluble contrast agent for use in the intrathecal space. Extensive animal and clinical studies have demonstrated its low toxicity. The advantages to the use of metrizamide include the fact that it is miscible with cerebrospinal fluid and can fill narrow spaces, is sufficiently radiopaque to outline delicate structures within the central nervous system, is completely resorbed from the subarachnoid space, and, to date, has not been implicated in the formation of adhesive arachnoiditis. Application of metrizamide to the evaluation of neurologically diseased patients has included myelography, intracranial cisternography, and ventriculography, as well as various techniques in conjunction with computerized tomography. These various uses of metrizamide are discussed together with some indications and advantages. Metrizamide has now replaced Pantopaque and gas as the most commonly used intrathecal contrast agent at the University of Texas Health Science Center at Dallas.",
author = "Maravilla, {K. R.} and Edward Neuwelt and Diehl, {J. T.}",
year = "1979",
month = "9",
language = "English (US)",
volume = "5",
pages = "389--406",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Application of metrizamide in the radiographic evaluation of the neurologically diseased patient.

AU - Maravilla, K. R.

AU - Neuwelt, Edward

AU - Diehl, J. T.

PY - 1979/9

Y1 - 1979/9

N2 - Metrizamide (Amipaque) is a new water-soluble contrast agent for use in the intrathecal space. Extensive animal and clinical studies have demonstrated its low toxicity. The advantages to the use of metrizamide include the fact that it is miscible with cerebrospinal fluid and can fill narrow spaces, is sufficiently radiopaque to outline delicate structures within the central nervous system, is completely resorbed from the subarachnoid space, and, to date, has not been implicated in the formation of adhesive arachnoiditis. Application of metrizamide to the evaluation of neurologically diseased patients has included myelography, intracranial cisternography, and ventriculography, as well as various techniques in conjunction with computerized tomography. These various uses of metrizamide are discussed together with some indications and advantages. Metrizamide has now replaced Pantopaque and gas as the most commonly used intrathecal contrast agent at the University of Texas Health Science Center at Dallas.

AB - Metrizamide (Amipaque) is a new water-soluble contrast agent for use in the intrathecal space. Extensive animal and clinical studies have demonstrated its low toxicity. The advantages to the use of metrizamide include the fact that it is miscible with cerebrospinal fluid and can fill narrow spaces, is sufficiently radiopaque to outline delicate structures within the central nervous system, is completely resorbed from the subarachnoid space, and, to date, has not been implicated in the formation of adhesive arachnoiditis. Application of metrizamide to the evaluation of neurologically diseased patients has included myelography, intracranial cisternography, and ventriculography, as well as various techniques in conjunction with computerized tomography. These various uses of metrizamide are discussed together with some indications and advantages. Metrizamide has now replaced Pantopaque and gas as the most commonly used intrathecal contrast agent at the University of Texas Health Science Center at Dallas.

UR - http://www.scopus.com/inward/record.url?scp=0018520170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018520170&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 389

EP - 406

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -